KIMBERLY MYERS: Open Payments
NPI 1366984734 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 123 payments from 19 companies in 2025. Trend: 2023 $474 · 2024 $1,197 · 2025 $2,639
Food & beverage: $2,639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $998 |
| Aimmune Therapeutics, Inc. | 17 | $262 |
| Madrigal Pharmaceuticals | 6 | $254 |
| Phathom Pharmaceuticals, Inc. | 9 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $192 |
| PFIZER INC. | 14 | $155 |
| Ardelyx, Inc. | 6 | $116 |
| GENZYME CORPORATION | 4 | $111 |
| Lilly USA, LLC | 3 | $56 |
| Gilead Sciences, Inc. | 2 | $56 |
Products named: SKYRIZI, RINVOQ, REZDIFFRA, ZENPEP, VOQUEZNA, ENTYVIO, DUPIXENT, IBSRELA.
Industry payments across NC — which companies pay providers there.
